XBiotech Inc.

XBIT · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.1B · 85 employees
139
SEC Filings
$1.87
Close 2026-11-05
85
Employees

Business Summary

XBiotech Inc. is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from natural human immune responses. The company sold its anti-IL-1a antibody Bermekimab for $750 million in 2019 and is now developing Natrunix (anti-IL-1a) for oncology and rheumatology, Hutrukin for stroke, and a pipeline of anti-infective antibodies targeting MRSA, C. difficile, shingles, and influenza. XBiotech operates a 48-acre research and manufacturing campus in Austin, Texas, and is a fully integrated biopharmaceutical developer.

Latest Stock Quote

XBIT 2026-11-05 $1.87 O:$1.95 H:$2.005 L:$1.852 Vol:0.0M VWAP:$1.8894
origin leaf: null

Next Earnings

expected 2027-01-25

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-132025-12-310001171843-26-001561EDGAR36K words
2025-03-182024-12-310001171843-25-001527EDGAR36K words
2024-03-152023-12-310001171843-24-001382EDGAR36K words
2023-03-152022-12-310001171843-23-001705EDGAR42K words
2022-03-152021-12-310001171843-22-001904EDGAR46K words
2021-03-162020-12-310001171843-21-001828EDGAR48K words
2020-03-162019-12-310001171843-20-001761EDGAR43K words
2019-03-142018-12-310001171843-19-001708EDGAR42K words
2018-03-162017-12-310001171843-18-002043EDGAR43K words
2017-03-162016-12-310001171843-17-001571EDGAR43K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-122026-09-300001171843-26-007383EDGAR13K words
2026-08-132026-06-300001171843-26-005492EDGAR13K words
2025-11-122025-09-300001171843-25-007233EDGAR13K words
2025-08-132025-06-300001171843-25-005368EDGAR13K words
2025-05-142025-03-310001171843-25-003178EDGAR11K words
2024-11-132024-09-300001171843-24-006336EDGAR14K words
2024-08-122024-06-300001171843-24-004689EDGAR13K words
2024-05-102024-03-310001171843-24-002746EDGAR11K words
2023-11-092023-09-300001171843-23-006944EDGAR17K words
2023-08-112023-06-300001171843-23-005261EDGAR16K words
2023-05-102023-03-310001171843-23-003144EDGAR13K words
2022-11-092022-09-300001171843-22-007285EDGAR17K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-10-260001171843-26-006810EDGAR3K words
2025-12-090001171843-25-007836EDGAR1K words
2025-10-030001171843-25-006266EDGAR4K words
2025-09-020001171843-25-005673EDGAR1K words
2025-06-240001171843-25-004066EDGAR1K words
2025-04-070001171843-25-002067EDGAR1K words
2025-04-010001171843-25-001876EDGAR1K words
2024-12-310001171843-24-007128EDGAR1K words
2024-06-200001171843-24-003541EDGAR1K words
2024-01-040001171843-24-000056EDGAR5K words

139 total filings indexed. 107 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

inflammatory-diseases oncology rheumatology neurology-(stroke) infectious-diseases biopharmaceutical-manufacturing true-human-monoclonal-antibody-technology proprietary-manufacturing-technology-for-reduced-cost-and-time-to-launch

Company Identity

CIK0001626878
TickerXBIT
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedA1
HeadquartersAustin, Texas
Websitehttp://www.xbiotech.com
Listed2015-04-15

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: df9f041fff84926af894d1151a73b0aced5cf0962d79a63e4625b78a43e47084
parent: a62eee23f335496a55e472e254a13e9c3dab6a0dcd9683a2c99f5823e334e8cc
content hash: f49b8c772fac0aca1b42df6da1a6bca2013cd93a8187659df50d0621fe071e2f
signed: 2026-11-16T19:05:38.747Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up XBIT using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on XBIT, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/XBIT (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.